Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interaction between Neuromelanin and Alpha-Synuclein in Parkinson’s Disease
Shengli Xu, Piu Chan
Biomolecules (2015) Vol. 5, Iss. 2, pp. 1122-1142
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity
Simona S. Ghanem, Nour K. Majbour, Nishant N. Vaikath, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 15
Open Access | Times Cited: 108
Neuromelanin in Parkinson’s Disease: Tyrosine Hydroxylase and Tyrosinase
Toshiharu Nagatsu, Akira Nakashima, Hirohisa Watanabe, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4176-4176
Open Access | Times Cited: 92
α-Synuclein in Parkinson’s disease: causal or bystander?
Peter Riederer, Daniela Berg, Nicolas Casadei, et al.
Journal of Neural Transmission (2019) Vol. 126, Iss. 7, pp. 815-840
Closed Access | Times Cited: 99
Parkinson’s disease and pesticides: A meta-analysis of disease connection and genetic alterations
Hussien Ahmed, Abdelrahman Ibrahim Abushouk, Mohamed Gabr, et al.
Biomedicine & Pharmacotherapy (2017) Vol. 90, pp. 638-649
Closed Access | Times Cited: 98
New hope for Parkinson's disease treatment: Targeting gut microbiota
Hongxia Fan, Shuo Sheng, Feng Zhang
CNS Neuroscience & Therapeutics (2022) Vol. 28, Iss. 11, pp. 1675-1688
Open Access | Times Cited: 43
Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion‐like behaviour of alpha‐synuclein
Nolwen L. Rey, Sonia George, Patrik Brundin
Neuropathology and Applied Neurobiology (2015) Vol. 42, Iss. 1, pp. 51-76
Closed Access | Times Cited: 67
Melanin and neuromelanin binding of drugs and chemicals: toxicological implications
Oskar Karlsson, Nils Gunnar Lindquist
Archives of Toxicology (2016) Vol. 90, Iss. 8, pp. 1883-1891
Closed Access | Times Cited: 66
Rasagiline and selegiline modulate mitochondrial homeostasis, intervene apoptosis system and mitigate α-synuclein cytotoxicity in disease-modifying therapy for Parkinson’s disease
Makoto Naoi, Wakako Maruyama, Masayo Shamoto‐Nagai
Journal of Neural Transmission (2020) Vol. 127, Iss. 2, pp. 131-147
Closed Access | Times Cited: 50
Role of Ionizing Radiation in Neurodegenerative Diseases
Neel Sharma, Rupali Sharma, Deepali Mathur, et al.
Frontiers in Aging Neuroscience (2018) Vol. 10
Open Access | Times Cited: 58
Metabolic Investigations of the Molecular Mechanisms Associated with Parkinson’s Disease
Robert Powers, Shulei Lei, Annadurai Anandhan, et al.
Metabolites (2017) Vol. 7, Iss. 2, pp. 22-22
Open Access | Times Cited: 51
Association Between Parkinson’s Disease and Melanoma: Putting the Pieces Together
Qing Ye, Ya Wen, Nasser Al-Kuwari, et al.
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 41
α‐Synuclein phase separation and amyloid aggregation are modulated by C‐terminal truncations
Shuai Huang, Xiaoli Mo, Jieyi Wang, et al.
FEBS Letters (2022) Vol. 596, Iss. 11, pp. 1388-1400
Closed Access | Times Cited: 27
Selective Neuronal Death in Neurodegenerative Diseases: The Ongoing Mystery.
Srinivasa Subramaniam
PubMed (2019) Vol. 92, Iss. 4, pp. 695-705
Closed Access | Times Cited: 36
The α-Synuclein Seeding Amplification Assay for Parkinson’s Disease
Ling Yi, Eng‐King Tan, Zhidong Zhou
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 389-389
Open Access
Induction of Ferroptotic Cell Death by Neuromelanin Pigments in Dopaminergic Cells
Gizem Kaftan, Güliz Armağan
ACS Chemical Neuroscience (2025)
Open Access
Cutaneous malignant melanoma and Parkinson disease: Common pathways?
Rivka Inzelberg, Shira Flash, Eitan Friedman, et al.
Annals of Neurology (2016) Vol. 80, Iss. 6, pp. 811-820
Closed Access | Times Cited: 38
Neuromelanin in Parkinson’s Disease: from Fenton Reaction to Calcium Signaling
Rainer Knörle
Neurotoxicity Research (2017) Vol. 33, Iss. 2, pp. 515-522
Closed Access | Times Cited: 36
Levodopa partially rescues microglial numerical, morphological, and phagolysosomal alterations in a monkey model of Parkinson’s disease
Cynthia Lecours, Marie‐Kim St‐Pierre, Katherine Picard, et al.
Brain Behavior and Immunity (2020) Vol. 90, pp. 81-96
Open Access | Times Cited: 31
Shared perturbations in the metallome and metabolome of Alzheimer’s, Parkinson’s, Huntington’s, and dementia with Lewy bodies: A systematic review
Melissa Scholefield, Richard D. Unwin, Garth J. S. Cooper
Ageing Research Reviews (2020) Vol. 63, pp. 101152-101152
Closed Access | Times Cited: 30
Catecholamines and Parkinson’s disease: tyrosine hydroxylase (TH) over tetrahydrobiopterin (BH4) and GTP cyclohydrolase I (GCH1) to cytokines, neuromelanin, and gene therapy: a historical overview
Toshiharu Nagatsu
Journal of Neural Transmission (2023) Vol. 131, Iss. 6, pp. 617-630
Closed Access | Times Cited: 10
Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease
Efrat Lasser-Katz, Alon Simchovitz, Wei‐Hua Chiu, et al.
Journal of Neuroscience (2016) Vol. 37, Iss. 1, pp. 47-57
Open Access | Times Cited: 31
Production, purification, and characterization of Streptomyces sp. strain MPPS2 extracellular pyomelanin pigment
Sinan Bayram
Archives of Microbiology (2021) Vol. 203, Iss. 7, pp. 4419-4426
Closed Access | Times Cited: 19
Immune system and new avenues in Parkinson’s disease research and treatment
Ava Nasrolahi, Fatemeh Safari, Mehdi Farhoudi, et al.
Reviews in the Neurosciences (2019) Vol. 30, Iss. 7, pp. 709-727
Closed Access | Times Cited: 20
Changes in cytoplasmic and extracellular neuromelanin in human substantia nigra with normal aging
Д. Э. Коржевский, О. В. Кирик, В. В. Гусельникова, et al.
European Journal of Histochemistry (2021) Vol. 65, Iss. s1
Open Access | Times Cited: 17
Potential of Diffusion Tensor Imaging and Relaxometry for the Detection of Specific Pathological Alterations in Parkinson's Disease (PD)
Regina Esterhammer, Klaus Seppi, Eva Reiter, et al.
PLoS ONE (2015) Vol. 10, Iss. 12, pp. e0145493-e0145493
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top